SCHEMBL15469642

SCHEMBL15469642

C#Cc1cnc2ccc(OC(SC)C(=O)NC(C)(C)c3cc(CC)on3)cc2c1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15469610 0.92 RAB9A (0.33) KDM4ERAB9ASMN1; SMN2
SCHEMBL15469611 0.89 KMT2A (0.33) RAB9A
SCHEMBL15469632 0.89 ALDH1A1 (0.31)
SCHEMBL15469664 0.88 RAB9A (0.32) KDM4ERAB9ASMN1; SMN2
SCHEMBL15469583 0.88 RAB9A (0.32) KDM4ERAB9ASMN1; SMN2
SCHEMBL15469653 0.87
SCHEMBL15469645 0.87
SCHEMBL15469599 0.87 ALDH1A1 (0.31)
SCHEMBL15469643 0.87
SCHEMBL15469581 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140045890-A1 NOVEL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2014-02-13 US disclosed
US-20140045890-A1 NOVEL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045890-A1 NOVEL COMPOUNDS CYP1B1, CYP1A1, CYP51A1 KDM4E 747/4885RAB9A 1433/4885SMN1; SMN2 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.